• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

avVaa World Health Care Products Inc. Announces DRTV Media Test Launches Today

Posted on: Monday, 5 October 2009, 06:45 CDT

LUMBY, BC, Oct. 5 /PRNewswire-FirstCall/ - avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the launch of its two week Neuroskin(R) Psoriasis Relief DRTV media test campaign.

avVaa World Health Care Products Inc. announced that its two week Neuroskin(R) Psoriasis Relief DRTV media test launched today, October 5, 2009. Over 100 informercial styled DRTV commercials will be shown on multiple networks over the next fourteen days. The DRTV spots direct customers to purchase Neuroskin(R) Psoriasis Relief via phone, or online at www.MyNeuroskin.com.

The Neuroskin(R) Psoriasis Relief DRTV commercials are in infomercial format and feature a 2 minute soft offer commercial, a 2 minute hard offer commercial, a 60 second commercial, and a 30 second commercial. The test will determine which campaign is most successful - the hard or the soft offer. The 60 and 30 second commercials are in soft offer format, and will allow avVaa to capitalize on free advertising spots secured by their media buyer.

"We have 102 scheduled spots over the next two week period," stated Lorie Campbell-Farley, President and Chief Operating Officer. "When all of the unscheduled free content is run, we anticipate we will have run over 120 commercials in total."

avVaa World Health Care Products Inc. has worked hard to ensure everything is in place to capitalize on this second DRTV media test. "We took what we learned from the last campaign and ran with it," commented Mrs. Campbell-Farley, "And our great line-up of vendors had made it easy to launch this test. Our credit card processing is running smoothly, and we have added eCheck as a payment option. Our telemarketing call centre has provided refresher training to its staff, and has prepared individual scripts for both the hard and soft offers. Our distributor has 17,000 bottles of Neuroskin(R) Psoriasis Relief in stock and ready to go."

avVaa anticipates a sales ration of at least 2:1, with two dollars in sales for every dollar spent marketing. "With the huge internet response we had on our first campaign, 2:1 is a conservative estimate," said Mrs. Campbell-Farley. "This time we are set to capitalize on every web order."

The DRTV Infomercials may be previewed using the following links: http://www.myneuroskin.com/120_hardsell_spot.html http://www.myneuroskin.com/120_softsell_spot.html http://www.myneuroskin.com/60_second_spot.html http://www.myneuroskin.com/30_second_spot.html

About avVaa World Health Care Products

avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin(R) line of skin care products through mass, food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: www.avvaa.com.

Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of avVaa World Health Care Products, Inc. and no assurance can be given that such results will be achieved.

Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.

CONTACT: avVaa World Health Care Products, Inquiries: info@avvaa.com; Investor Relations: Merle Goertz, (West Coast) (604) 688-2349

SOURCE avVaa World Health Care Products

Source: PR Newswire

More News in this Category